Renovis Surgical received FDA 510(k) clearance to market Tesera® porous titanium posterior lumbar interbody fusion systems.
All Tesera implants are made using additive manufacturing techniques and Tesera Trabecular Technology®, yielding a highly porous structure to support bone attachment.
This is Renovis’ fifth product group featuring Tesera. Earlier FDA-cleared products include Tesera SA for standalone anterior fusion, the Tesera acetabular system for total hip reconstruction, the original Tesera PLIF line and Tesera SC for standalone anterior cervical fusion.
Renovis Surgical received FDA 510(k) clearance to market Tesera® porous titanium posterior lumbar interbody fusion systems.
All Tesera implants are made using additive manufacturing techniques and Tesera Trabecular Technology®, yielding a highly porous structure to support bone attachment.
This is Renovis' fifth product group featuring...
Renovis Surgical received FDA 510(k) clearance to market Tesera® porous titanium posterior lumbar interbody fusion systems.
All Tesera implants are made using additive manufacturing techniques and Tesera Trabecular Technology®, yielding a highly porous structure to support bone attachment.
This is Renovis’ fifth product group featuring Tesera. Earlier FDA-cleared products include Tesera SA for standalone anterior fusion, the Tesera acetabular system for total hip reconstruction, the original Tesera PLIF line and Tesera SC for standalone anterior cervical fusion.
Copy to clipboard 
